| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4182447 | L'Encéphale | 2010 | 4 Pages |
Abstract
Treatment of maternal depression during pregnancy and immediate neonatal period is uniformly recommended despite the potential side effects on the fetus and newborn. With a possible exception for paroxetine, maternal treatment with SSRIs during pregnancy is not associated with significantly increased risks of congenital defects.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
M. Soufia, J. Aoun, M.-A. Gorsane, M.-O. Krebs,